Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells (Q43525505)

24 November 2017

Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells (English)

1 reference

24 November 2017

1 reference

1 reference

2

1 reference

24 November 2017

Benbrik E

1

1 reference

24 November 2017

Bonavaud S

3

1 reference

24 November 2017

Ammi-Saïd M

4

1 reference

24 November 2017

Frisdal E

5

1 reference

24 November 2017

Rey C

6

1 reference

24 November 2017

Gherardi R

7

1 reference

24 November 2017

Barlovatz-Meimon G

8

1 reference

24 November 2017

1 July 1997

1 reference

Journal of the Neurological Sciences

24 November 2017

1 reference

24 November 2017

149

1 reference

24 November 2017

1

1 reference

24 November 2017

19-25

1 reference

Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Partial cytochrome c oxidase deficiency and cytoplasmic bodies in patients with zidovudine myopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Myopathy and HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Muscle involvement in human immunodeficiency virus-infected patients is associated with marked selenium deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

A microtiter plate assay for cytochrome c oxidase in permeabilized whole cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Mitochondrial myopathy caused by long-term zidovudine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Human myotube differentiation in vitro in different culture conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Effects of 2',3'-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Schwann cell mitochondrial alterations in peripheral nerves of rabbits treated with 2',3'-dideoxycytidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Preparation and properties of NADH: ubiquinone oxidoreductase (complexI), EC 1.6.5.3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Massive conversion of guanosine to 8-hydroxy-guanosine in mouse liver mitochondrial DNA by administration of azidothymidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Cellular targets of 3'-azido-3'-deoxythymidine: an early (non-delayed) effect on oxidative phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Satellite cell myogenesis is highly stimulated by the kinase inhibitor iso-H7: comparison with HA1004 and staurosporine effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Mitochondrial toxicity of antiviral drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

10.1016/S0022-510X(97)05376-8

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference